Wegovy Weight-Loss Pill Sparks Strong Demand in Dubai as First-Time Patients Turn to Tablets Instead of Injections
Rania Khani, Pharmacy Manager at International Modern Hospital Dubai, reports growing interest in oral weight-loss treatments, particularly among patients who previously avoided injectable medications.
Dubai: The introduction of the oral Wegovy weight-loss medication in the UAE is generating strong interest among patients seeking alternatives to injectable treatments, with International Modern Hospital Dubai reporting growing demand for the newly available tablets.
Rania Khani, Pharmacy Manager at International Modern Hospital Dubai, said the availability of an oral formulation is encouraging patients who previously hesitated to explore prescription weight-loss treatments, particularly those who prefer taking tablets rather than receiving injections.
“We have seen strong demand for oral weight-loss pills, especially among patients who prefer tablets over injectables,” Khani said.
She explained that the availability of different treatment formulations gives patients more options when discussing medically supervised weight management with their healthcare providers.
Why are patients choosing pills over injections?
According to Khani, convenience and personal preference are important factors influencing interest in oral weight-loss medications.
For some patients, the idea of taking a tablet may be more appealing than using an injectable treatment, particularly if they are uncomfortable with needles or have never previously used prescription medication for weight management.
The oral formulation may therefore encourage more people to seek medical advice about obesity treatment.
However, Khani emphasised the importance of ensuring that patients understand that prescription weight-loss medications require proper medical assessment and should not be selected solely on the basis of convenience.
All four Wegovy strengths available at International Modern Hospital Dubai
Khani confirmed that International Modern Hospital Dubai has all four strengths of the oral Wegovy medication: 1.5mg, 4mg, 9mg and 25mg.
The availability of multiple strengths allows patients to obtain their prescribed medication according to the treatment plan established by their healthcare provider.
The reported prices in the UAE are:
| Wegovy tablet strength | Reported price |
|---|---|
| 1.5mg | Dh779 |
| 4mg | Dh779 |
| 9mg | Dh1,199 |
| 25mg | Dh1,610 |
Prices may vary between pharmacies, and patients should confirm current availability and pricing before purchasing.
How does oral Wegovy help with weight management?
Wegovy contains semaglutide, a medication that acts on GLP-1 receptors involved in appetite regulation.
It helps patients feel fuller and may reduce food intake, supporting weight loss when combined with a balanced diet and regular physical activity.
Unlike injectable formulations administered weekly, oral Wegovy is taken daily according to specific instructions designed to support appropriate absorption.
Patients must follow the prescribed dosing schedule and should never increase their dose without medical guidance.
Why pharmacist guidance matters
Khani highlighted the important role pharmacists play in helping patients understand how to use prescription weight-loss medications safely.
Patients considering oral semaglutide should receive clear information about correct administration, potential side effects, medication interactions and the importance of following their prescribed treatment plan.
Common gastrointestinal side effects may include nausea, vomiting, constipation, diarrhoea and abdominal discomfort, particularly when treatment begins or the dose is increased.
Patients should also understand that the medication is not appropriate for everyone and requires medical assessment before initiation.
Growing interest in medically supervised weight management
Khani said the demand reported at International Modern Hospital Dubai reflects increasing patient interest in oral weight-loss medication.
For individuals who have been reluctant to use injectable therapies, the availability of tablets offers another opportunity to discuss treatment options with a qualified healthcare professional.
The growing popularity of oral Wegovy also highlights the importance of ensuring that patients receive reliable information about the medication rather than making treatment decisions based on social media trends or personal recommendations.
Khani stressed that the choice of weight-loss treatment should always be guided by medical suitability, safety and the patient’s long-term health goals.
As oral weight-loss medications become more accessible, pharmacists are expected to play an increasingly important role in patient education, safe medication use and supporting adherence to prescribed treatment plans.
